Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2

被引:73
|
作者
Ma, Xue [1 ,2 ]
Lian, Qing-Quan [3 ]
Dong, Qiang [2 ]
Ge, Ren-Shan [1 ,3 ]
机构
[1] Populat Council, New York, NY 10065 USA
[2] Sichuan Univ, W China Hosp, Dept Urol, Chengdu 610041, Sichuan, Peoples R China
[3] Wenzhou Med Coll, Affiliated Hosp 2, Wenzhou 32500, Zhejiang, Peoples R China
关键词
11 beta-Hydroxysteroid dehydrogenase type 2; Glucocorticoid; Inhibitor; Toxicity; Gossypol; Phthalates; Organotins; Alkylphenols; Perfluorinated substances; BETA-HYDROXYSTEROID DEHYDROGENASE; LEYDIG-CELLS; IN-UTERO; TRIBUTYLTIN CHLORIDE; GLYCYRRHETINIC ACID; ENDOTHELIAL-CELLS; CANCER CELLS; HUMAN KIDNEY; II ENZYME; RAT;
D O I
10.1016/j.tox.2011.04.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
11 beta-Hydroxysteroid dehydrogenase (11 beta-HSID) regulates glucocorticoid action by catalyzing the inter-conversion of active cortisol and inactive cortisone in glucocorticoid and mineralocorticoid target tissues. Two distinct isoforms, 11 beta-HSD1 and 11 beta-HSD2, have been characterized. 11 beta-HSD1 is widely expressed, uses NADP+/NADPH as cofactors, and contributes to the metabolic syndrome and related conditions by increasing cortisol level. 11 beta-HSD2 is an NAD(+)-dependent oxidase, converting cortisol to cortisone to lower active glucocorticoid level. The inhibition of 11 beta-HSD2 activity is generally detrimental to health because the buildup of local cortisol concentration can cause symptoms of apparent mineralocorticoid excess, fetal developmental defect and lower testosterone level in males. In this review, we focus on many environmental inhibitors of 11 beta-HSD2 including licorice components, gossypol, phthalates, organotins, alkylphenols and perfluorinated substances. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 50 条
  • [1] 11β-hydroxysteroid dehydrogenase type 1 inhibitors
    Boyle, Craig D.
    Kowalski, Timothy J.
    Zhang, Lili
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 41, 2006, 41 : 127 - 140
  • [2] 11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
    Morgan, Stuart A.
    Tomlinson, Jeremy W.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (09) : 1067 - 1076
  • [3] Selective 11β-hydroxysteroid dehydrogenase type 1 inhibitors
    Blum, A
    Maser, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R147 - R148
  • [4] Piperidine amides as 11β-hydroxysteroid dehydrogenase type 1 inhibitors
    Flyren, Katarina
    Bergquist, Lars O.
    Castro, Victor M.
    Fotsch, Christopher
    Johansson, Lars
    Jean, David J. St., Jr.
    Sutin, Lori
    Williams, Meredith
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3421 - 3425
  • [5] Oxazolones as potent inhibitors of 11β-hydroxysteroid dehydrogenase type 1
    Sutin, Lori
    Andersson, Soeren
    Bergquist, Lars
    Castro, Victor M.
    Danielsson, Eva
    James, Stephen
    Henriksson, Martin
    Johansson, Lars
    Kaiser, Christina
    Flyren, Katarina
    Williams, Meredith
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (17) : 4837 - 4840
  • [6] 11β-hydroxysteroid dehydrogenase type 1 inhibitors as therapeutic agents
    Webster, Scott Peter
    Pallin, Thomas David
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (12) : 1407 - 1422
  • [7] Small Molecule 11β- Hydroxysteroid Dehydrogenase Type 1 Inhibitors
    Sun, Daqing
    Wang, Minghan
    Wang, Zhulun
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (12) : 1464 - 1475
  • [8] Perhydroquinolylbenzamides as novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1
    Coppola, GM
    Kukkola, PJ
    Stanton, JL
    Neubert, AD
    Marcopulos, N
    Bilci, NA
    Wang, H
    Tomaselli, HC
    Tan, J
    Aicher, TD
    Knorr, DC
    Jeng, AY
    Dardik, B
    Chatelain, RE
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) : 6696 - 6712
  • [9] 11β-Hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome
    Schnackenberg, Christine G.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (03) : 295 - 300
  • [10] Recent advances in the study of 11β-Hydroxysteroid dehydrogenase type 2 (11β-HSD2)Inhibitors
    Zhou, Chunchun
    Ye, Fan
    Wu, He
    Ye, Hui
    Chen, Quanxu
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2017, 52 : 47 - 53